MEOH vs UFPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MEOH exhibits a severe disconnect between its current market price ($59.75) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $25.71 suggesting significant overvaluation. While the stock has seen a massive 123% 1-year price surge, this is not supported by fundamentals, as YoY EPS growth has plummeted by 111.3% and profit margins have shrunk to a razor-thin 2.22%. The high payout ratio (79.57%) combined with declining earnings creates a risk to dividend sustainability. Despite analyst 'buy' ratings, the deterministic metrics signal a speculative bubble or an over-optimistic anticipation of a cyclical recovery.
UFPI presents a stark dichotomy between a pristine balance sheet and deteriorating operational performance. With a Piotroski F-Score of 4/9, the company is fundamentally stable but lacks growth momentum, evidenced by a -39.7% YoY earnings decline and four consecutive quarterly misses. The stock trades at $96.20, significantly above its Graham Number ($78.02) and far above its Intrinsic Value ($35.00), suggesting a valuation premium that is not supported by current fundamentals. While exceptionally low debt provides a safety net, the bearish technical trend and negative growth trajectory outweigh the optimistic analyst consensus.
Compare Another Pair
Related Comparisons
MEOH vs UFPI: Head-to-Head Comparison
This page compares Methanex Corporation (MEOH) and UFP Industries, Inc. (UFPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.